Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria.
We assessed the efficacy of silver oxide coating of the indwelling urethral catheter and catheter adapter, and instillation of trichloroisocyanuric acid into the urinary drainage bag in the prevention of catheter-associated bacteriuria in a prospective and randomized study of 74 patients. Bacteriuria was documented in 29 of the 74 patients (39 per cent). There was a significant difference between the attack rates, with 11 of 41 patients (27 per cent) in the test group and 18 of 33 (55 per cent) in the control group having bacteriuria (p equals 0.02) after a median time to bacteriuria of 36 and 8 days, respectively (p equals 0.01). Urethral meatal colonization was implicated as the source of bladder bacteriuria in 12 of 18 patients (67 per cent) in the control group and 5 of 11 (45 per cent) in the test group. Trichloroisocyanuric acid significantly reduced drainage bag contamination but bag contamination with the same microorganism responsible for bacteriuria preceded infection in only 2 of the 29 patients (7 per cent), 1 in each group. Patients who received systemic antimicrobial agents acquired bacteriuria less frequently than those who did not. The apparent protective effect of systemic antimicrobials was strongest during the first 4 days of catheterization. The data indicate that episodes of bacteriuria arising from the urethral meatus are common among catheterized patients and that the antimicrobial catheter is effective in reducing the incidence of catheter-associated bacteriuria.
Schaeffer
A J
AJ
Department of Urology, Northwestern University Medical School, Chicago, Illinois.
Story
K O
KO
Johnson
S M
SM
D000328:Adult; D001419:Bacteria / Q000302:isolation & purification; D001437:Bacteriuria / Q000382:microbiology / Q000517:prevention & control*; D002408:Catheters, Indwelling / Q000009:adverse effects; D003422:Critical Care; D003556:Cystitis / Q000382:microbiology / Q000517:prevention & control; D004866:Equipment Contamination / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D010087:Oxides / Q000627:therapeutic use*; D012834:Silver / Q000627:therapeutic use*; D018030:Silver Compounds; D013119:Spinal Cord Injuries / Q000150:complications; D014227:Triazines / Q000627:therapeutic use*; D014521:Urethra / Q000382:microbiology; D001743:Urinary Bladder / Q000382:microbiology
D010087:Oxides; D018030:Silver Compounds; D014227:Triazines; D012834:Silver; C040225:disilver oxide; C051718:symclosene